T. Hari Babu
T. Hari Babu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Nageena Taj
3 shared publicationsUday Raj Sharma
Department of Pharmacology Acharya & BM Reddy College of Pharmacy 560107 Bangalore- India
3 shared publicationsArchana Bg
2 shared publicationsManjunatha Panduranga Mudagal
Department of Pharmacology Acharya & BM Reddy College of Pharmacy 560107 Bangalore- India
2 shared publications- Manjunatha Panduranga Mudgal
Acharya & BM Reddy College of Pharmacy, Bengaluru, 560107, Karnataka, India
2 shared publications Preeti P Angadi
Department of Pharmacology Acharya & BM Reddy College of Pharmacy 560107 Bangalore- India
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by European Alliance for Innovation n.o.
The Gut-Brain Connection: Exploring the Influence of the Microbiome on Colon Cancer Development and Treatment
The gut-brain axis is an intricate bidirectional communication system between the gastrointestinal tract and the central nervous system that the gut microbiota can commonly influence. Recent studies have shown that the gut microbiome is crucial for colorectal cancer development and progression. The focus is on the close interaction between the gut microbiota and the development of colon cancer by explaining the microbial composition, metabolic byproducts and immune modulation. We also investigated how dysbiosis can promote carcinogenesis through inflammation, genotoxicity and immune evasion. In addition, we consider promising microbiotatargeted therapeutic approaches, such as the use of probiotics and faecal microbiota transplantation, together with the development of biotherapeutics and their ability to improve conventional colon cancer treatments. By elucidating the gut-brain-microbiome interplay, this manuscript aims to provide a comprehensive understanding of its impact on colon cancer, opening new avenues for innovative and effective treatment modalities.
- 1 January 2025
- Published by European Alliance for Innovation n.o.
Open AccessThe Gut-Brain Connection: Exploring the Influence of the Microbiome on Colon Cancer Development and Treatment
The gut-brain axis is an intricate bidirectional communication system between the gastrointestinal tract and the central nervous system that the gut microbiota can commonly influence. Recent studies have shown that the gut microbiome is crucial for colorectal cancer development and progression. The focus is on the close interaction between the gut microbiota and the development of colon cancer by explaining the microbial composition, metabolic byproducts and immune modulation. We also investigated how dysbiosis can promote carcinogenesis through inflammation, genotoxicity and immune evasion. In addition, we consider promising microbiotatargeted therapeutic approaches, such as the use of probiotics and faecal microbiota transplantation, together with the development of biotherapeutics and their ability to improve conventional colon cancer treatments. By elucidating the gut-brain-microbiome interplay, this manuscript aims to provide a comprehensive understanding of its impact on colon cancer, opening new avenues for innovative and effective treatment modalities.
- Open Access
- 1 January 2025
- Published by European Alliance for Innovation n.o.
Impact of Environmental Exposure, Risk factors, Biomarkers in Parkinson’s Disease: A Brief and Comprehensive review
Parkinson's disease (PD) is defined by the progressive death of nigrostriatal dopaminergic neurons, which is accompanied with intracellular Lewy bodies. The condition is influenced not only by genetic predispositions but also by environmental factors. This paper reviews the pivotal role of environmental exposure risk factors-such as pesticides, heavy metals, solvents, and air pollutants in the development and progression of parkinsonism. It delves into the mechanisms through which these environmental toxins instigate neurodegeneration, exacerbating the underlying pathology. Moreover, the review discusses the emerging significance of biomarkers in assessing environmental exposure levels and predicting individual susceptibility to parkinsonism. Biomarkers offer promise in unravelling the intricate biological processes involved in disease onset and evolution, potentially enabling early detection and intervention strategies. Understanding the intricate interplay between environmental exposures, biomarkers, and parkinsonism is paramount for devising preventive measures and targeted therapeutic interventions.
- 1 January 2025
- Published by European Alliance for Innovation n.o.
Open AccessImpact of Environmental Exposure, Risk factors, Biomarkers in Parkinson’s Disease: A Brief and Comprehensive review
Parkinson's disease (PD) is defined by the progressive death of nigrostriatal dopaminergic neurons, which is accompanied with intracellular Lewy bodies. The condition is influenced not only by genetic predispositions but also by environmental factors. This paper reviews the pivotal role of environmental exposure risk factors-such as pesticides, heavy metals, solvents, and air pollutants in the development and progression of parkinsonism. It delves into the mechanisms through which these environmental toxins instigate neurodegeneration, exacerbating the underlying pathology. Moreover, the review discusses the emerging significance of biomarkers in assessing environmental exposure levels and predicting individual susceptibility to parkinsonism. Biomarkers offer promise in unravelling the intricate biological processes involved in disease onset and evolution, potentially enabling early detection and intervention strategies. Understanding the intricate interplay between environmental exposures, biomarkers, and parkinsonism is paramount for devising preventive measures and targeted therapeutic interventions.
- Open Access
- 1 January 2025
- Published by European Alliance for Innovation n.o.
Experimental Models of Chronic Kidney Disease – A Review
Study on chronic kidney disease (CKD) requires reliable animal models because it is a major worldwide health concern. It has a substantial global health burden, a variety of etiologies, and complicated progression pathways. The many in vivo models used in CKD research are thoroughly analysed in this review. The models are grouped according to the etiology of CKD, which includes drug-induced nephrotoxicity, glomerulonephritis, diabetic nephropathy, and hypertension-induced renal damage. Each model's benefits and drawbacks are discussed with an emphasis on how relevant each is to a particular CKD pathology. New developments like genetically modified models and sophisticated imaging methods are examined. It is emphasized how crucial translational research is to verifying results from studies conducted on animals that are applied to humans. To sum up, this review highlights how important in vivo models are to understanding the pathophysiology of CKD and to developing new treatments. Including a variety of models that capture the complexity of CKD facilitates understanding.
- 1 January 2025
- Published by European Alliance for Innovation n.o.
Open AccessExperimental Models of Chronic Kidney Disease – A Review
Study on chronic kidney disease (CKD) requires reliable animal models because it is a major worldwide health concern. It has a substantial global health burden, a variety of etiologies, and complicated progression pathways. The many in vivo models used in CKD research are thoroughly analysed in this review. The models are grouped according to the etiology of CKD, which includes drug-induced nephrotoxicity, glomerulonephritis, diabetic nephropathy, and hypertension-induced renal damage. Each model's benefits and drawbacks are discussed with an emphasis on how relevant each is to a particular CKD pathology. New developments like genetically modified models and sophisticated imaging methods are examined. It is emphasized how crucial translational research is to verifying results from studies conducted on animals that are applied to humans. To sum up, this review highlights how important in vivo models are to understanding the pathophysiology of CKD and to developing new treatments. Including a variety of models that capture the complexity of CKD facilitates understanding.
- Open Access
- 24 December 2024
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 10 (1) , 65-71
A Systemic Review of Beta Caryophyllene
A naturally occurring sesquiterpene known as..........
- 24 December 2024
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 10 (1) , 65-71
Open AccessA Systemic Review of Beta Caryophyllene
A naturally occurring sesquiterpene known as..........
- 9 October 2024
- Published by Springer Nature in Current Pharmacology Reports
- p. 1-10
Immune Mechanisms in Alzheimer’s Disease: The Role of Toll-Like Receptors Signalling
- 9 October 2024
- Published by Springer Nature in Current Pharmacology Reports
- p. 1-10
Immune Mechanisms in Alzheimer’s Disease: The Role of Toll-Like Receptors Signalling
- Open Access
- 1 January 2023
- Published by Rajiv Gandhi University of Health Sciences in Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences
- Vol. 13 (3)
Development of Dendrimer-5-Flurouracil and Folic acid Conjugation for the Treatment of Colon Cancer via Target Drug Delivery
Background Cancer cells are also known as carcinoma sarcoma melanoma lyphoma and leukemia. The ability of the bodys immune cells to recognise and eliminate newly formed cells when there arent many of them is probably more crucial to the development of cancer than the conversion of a normal cell into a malignant cell. Colonic epithelial cells which line the lumen of the organ and replace themselves every five days from a stem cell population found at the base of colonic epithelial cell crypts are the source of colon cancers.Aim To develop a Dendrimer of 5-Flurouracil and Folic acid conjugate for the treatment of colon cancer via target drug delivery.Methods The dendrimers of 5-Flurouracil and Folic acid conjugate were developed involving the following steps- formulation of dendrimer of antineoplastic drugs dendrimer Acylated Dendrimer characterization of compounds and in ndash vivo anti - cancer activity.Results On 7th and 14th a significant decrease in WBC increase in RBC and increase in Haemoglobin was observed compared to Cancer control.Conclusion It has been concluded that cancer induction in mice Groups I II III results in decreased RBC and Hb levels along with an increase in WBC count. Treatment with drugs restores the abnormal hematopoietic system parameters to normal levels in cancer-bearing mice.
- 1 January 2023
- Published by Rajiv Gandhi University of Health Sciences in Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences
- Vol. 13 (3)
Open AccessDevelopment of Dendrimer-5-Flurouracil and Folic acid Conjugation for the Treatment of Colon Cancer via Target Drug Delivery
Background Cancer cells are also known as carcinoma sarcoma melanoma lyphoma and leukemia. The ability of the bodys immune cells to recognise and eliminate newly formed cells when there arent many of them is probably more crucial to the development of cancer than the conversion of a normal cell into a malignant cell. Colonic epithelial cells which line the lumen of the organ and replace themselves every five days from a stem cell population found at the base of colonic epithelial cell crypts are the source of colon cancers.Aim To develop a Dendrimer of 5-Flurouracil and Folic acid conjugate for the treatment of colon cancer via target drug delivery.Methods The dendrimers of 5-Flurouracil and Folic acid conjugate were developed involving the following steps- formulation of dendrimer of antineoplastic drugs dendrimer Acylated Dendrimer characterization of compounds and in ndash vivo anti - cancer activity.Results On 7th and 14th a significant decrease in WBC increase in RBC and increase in Haemoglobin was observed compared to Cancer control.Conclusion It has been concluded that cancer induction in mice Groups I II III results in decreased RBC and Hb levels along with an increase in WBC count. Treatment with drugs restores the abnormal hematopoietic system parameters to normal levels in cancer-bearing mice.